• Hausa Edition
  • Podcast
  • Conferences
  • LeVogue Magazine
  • Business News
  • Print Advert Rates
  • Online Advert Rates
  • Contact Us
Monday, December 22, 2025
Leadership Newspapers
Read in Hausa
  • Home
  • News
  • Politics
  • Business
  • Sport
    • Football
  • Health
  • Entertainment
  • Education
  • Opinion
    • Editorial
    • Columns
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us
No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
    • Football
  • Health
  • Entertainment
  • Education
  • Opinion
    • Editorial
    • Columns
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us
No Result
View All Result
Leadership Newspapers
No Result
View All Result

Louisiana Gov’t Classifies Abortion Drugs As Dangerous Substances

Ruth Nwokwu by Ruth Nwokwu
2 years ago
in Health
Louisiana
Share on WhatsAppShare on FacebookShare on XTelegram

Louisiana Republican Governor, Jeff Landry has signed a bill classifying abortion inducing pills, misoprotol and mifepristone as Schedule IV controlled dangerous substances.

Landry took to his X (formerly Twitter) handle to make this announcement on Friday where he emphasised that the bill, now signed into law would protect women across Louisiana.

He wrote, “Requiring an abortion inducing drug to be obtained with a prescription and criminalising the use of an abortion drug on an unsuspecting mother is nothing short of common sense. This bill protects women across Louisiana and I was proud to sign this bill into law today.”

Under the Law, these abortion drugs are placed under the same category as narcotics and depressants.

It is now crime to possess them without a prescription as well as to administer them without a person’s consent.

With exemption of pregnant women, anyone found in possession of misoprotol and mifepristone without a valid prescription could be charged to 5 years in prison and fines of about $5,000.

RELATED NEWS

Federal Government Approves ₦32.9bn To Boost Primary Healthcare Access

Fidson Healthcare To Raise N21bn Rights Issue For Production, Expansion

Stakeholders Call For Affordable Healthcare As Taraba Launches Health Forum

Lagos Launches LASHMA-AID To End Emergency Care Denials

Hundreds of health care providers in the state have raised concerns over this reclassification.
According them, Mifepristone and Misoprotol have other medical advantages, miscarriage care inclusive.

They warned that outrightly classifying misoprotol and mifepristone as dangerous substances would create false perceptions around the medications’ in the mind of people and stop them from accessing necessary care.

“Requiring an abortion inducing drug to be obtained with a prescription and criminalizing the use of an abortion drug on an unsuspecting mother is nothing short of common sense.

“This bill protects women across Louisiana and I was proud to sign this bill into law today.”

Join Our WhatsApp Channel

OTHER NEWS UPDATES

Universal Health Coverage: Federal Govt To Revive 17,000 Primary Healthcare Centres
Health

Federal Government Approves ₦32.9bn To Boost Primary Healthcare Access

2 days ago
Fidson Invests ₦3.7bn To Boost Local Pharma Production In 2024
Health

Fidson Healthcare To Raise N21bn Rights Issue For Production, Expansion

3 days ago
Stakeholders Call For Affordable Healthcare As Taraba Launches Health Forum
Health

Stakeholders Call For Affordable Healthcare As Taraba Launches Health Forum

3 days ago
Advertisement

LATEST UPDATE

Multinationals Exit Pakistan Over Regulatory Hurdles, Others

4 hours ago

Dr. Faisal Shuaibu Is Bouncing Back: Why Old-Style Politics Has Failed

6 hours ago

Fubara’s Decision To Join APC Demonstrates Unconditional Loyalty To Tinubu – Hon. Mustapha

6 hours ago

DHQ Heightens Efforts To Ensure Hitch-free Christmas

7 hours ago

BREAKING: Remaining Abducted Niger Schoolchildren Freed As 130 Regain Freedom

7 hours ago
Load More

© 2025 Leadership Media Group - All Rights Reserved.

No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
    • Football
  • Health
  • Entertainment
  • Education
  • Opinion
    • Editorial
    • Columns
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us

© 2025 Leadership Media Group - All Rights Reserved.